Skip to main content

Association of Xba I allele (Xba I 44kb) of the human cytochrome P-450dbI (CYP2D6) gene in Japanese patients with idiopathic Parkinson’s disease

  • Conference paper
Parkinson’s Disease. From Clinical Aspects to Molecular Basis

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

Summary

Cytochrome P-450dbl gene (CYP2D6) Xba I genotypes were investigated in 43 unrelated healthy Japanese and 51 patients with idiopathic Parkinson’s disease (IPD), using genomic DNA hybridization analysis with a cDNA probe encoding cytochrome P- 450dbl. Restriction fragment length polymorphisms (RFLPs) were observed in both populations, but the frequencies of alleles detected by restriction enzyme Xba I differed significantly. The relative risk of IPD is 2.15 times greater for idividuals with a Xba I 44 kb allele compared to those without the allele (x2 = 4.149, d.f. = 1, p < 0.05). Furthermore, the relative risk of IPD is 6.32 times greater for the Xba I 44 kb homozygotes than the Xba I 29 kb homozygotes (x2 = 4.935, d.f. = 1, p < 0.05). These data suggest that the Xba I 44 kb allele of CYP2D6 is one of the genetic factors making humans susceptible to IPD acquisition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J (1985) Ecogenetics of Parkinson’s disease: 4-hydroxylation of debrisoquine. Lancet ii: 1213–1215

    Google Scholar 

  • Barbeau A, Roy M, Cloutier T, Plasse L, Paris S (1986) Environmental and genetic factors in the etiology of Parkinson’s disease. Adv Neurol 45: 299–306

    Google Scholar 

  • Fonne-Pfister R, Meyer UA (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol 37: 3829–3835

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331: 442–446

    Article  PubMed  CAS  Google Scholar 

  • Heim M, Meyer UA (1990) Genotyping of poor metabolisers of debrisoquine by allelespecific PCR amplification. Lancet 336: 529–532

    Article  PubMed  CAS  Google Scholar 

  • Ishizaki T, Eichelbaum M, Horai Y, Hashimoto K, Chiba K, Dengler HJ (1987) Evidence for polymorphic oxidation of sparteine in Japanese subjects. Br J Clin Pharmacol 23: 482–485

    PubMed  CAS  Google Scholar 

  • Kunkel LM, Smith KD, Bother SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74: 1245–1249

    Article  PubMed  CAS  Google Scholar 

  • Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analogy synthesis. Science 219: 979–980

    Article  PubMed  CAS  Google Scholar 

  • Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet ii: 584–586

    Google Scholar 

  • Nakamura K, Goto F, Ray WA, McAllester CB, Jacqz E, Wilkinson GR, Branch RA (1985) Interethnic differences in genetic polymorphism of debrisoquine and mephnytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 38: 402–408

    Article  PubMed  CAS  Google Scholar 

  • Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W (1990) The dopanime transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain; resolution and identification of two distinct [3H]-GBR- 12935 binding proteins. Arch Biochem Biophys 276: 424–432

    Article  PubMed  CAS  Google Scholar 

  • Shahi GS, Moochhala SM, Das NP (1989) Depression of the hepatic cytochrome P450 monooxygenase system by the neurotoxin l-methyl-4-phenyl-l,2,3,6- tetrahydropyridine (MPTP). Pharmacol Toxicol 64: 107–110

    Article  PubMed  CAS  Google Scholar 

  • Skoda RC, Gonzalez FJ, Demierre A, Meyer UA (1988) Two mutant alleles of the human cytochrome P-450dbl gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci USA 85: 5240–5243

    Article  PubMed  CAS  Google Scholar 

  • Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517

    Article  PubMed  CAS  Google Scholar 

  • Yue QY, Bertilsson L, Dahl-Puustinen ML, Sawe J, Sjogvist F, Johansson I, Ingelman- Sundberg M (1989) Dissassociation between debrisoquine hydroxylation phenotype and genotype among Chinese. Lancet ii: 870

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag/Wien

About this paper

Cite this paper

Kondo, I., Kanazawa, I. (1991). Association of Xba I allele (Xba I 44kb) of the human cytochrome P-450dbI (CYP2D6) gene in Japanese patients with idiopathic Parkinson’s disease. In: Nagatsu, T., Narabayashi, H., Yoshida, M. (eds) Parkinson’s Disease. From Clinical Aspects to Molecular Basis. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9146-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9146-0_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82272-2

  • Online ISBN: 978-3-7091-9146-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics